Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 48150-45-4 | MDL No. : | MFCD09475805 |
Formula : | C10H12BNO3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | GBBUBIKYAQLESK-UHFFFAOYSA-N |
M.W : | 205.02 | Pubchem ID : | 3016474 |
Synonyms : |
|
Num. heavy atoms : | 15 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.1 |
Num. rotatable bonds : | 4 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 3.0 |
Molar Refractivity : | 59.72 |
TPSA : | 69.56 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.86 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | 0.97 |
Log Po/w (WLOGP) : | -0.31 |
Log Po/w (MLOGP) : | 0.33 |
Log Po/w (SILICOS-IT) : | -0.64 |
Consensus Log Po/w : | 0.07 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.75 |
Solubility : | 3.61 mg/ml ; 0.0176 mol/l |
Class : | Very soluble |
Log S (Ali) : | -2.02 |
Solubility : | 1.96 mg/ml ; 0.00958 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -2.13 |
Solubility : | 1.53 mg/ml ; 0.00745 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 2.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.9 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 99349-68-5 ]
(3-Acrylamidophenyl)boronic acid
Similarity: 0.89
[ 101251-09-6 ]
4-Acetylaminophenylboronic acid
Similarity: 0.86
[ 1217500-61-2 ]
(2-Oxoindolin-6-yl)boronic acid
Similarity: 0.77
[ 850568-22-8 ]
(4-((2-(Dimethylamino)ethyl)carbamoyl)phenyl)boronic acid hydrochloride
Similarity: 0.76
[ 99349-68-5 ]
(3-Acrylamidophenyl)boronic acid
Similarity: 0.89
[ 101251-09-6 ]
4-Acetylaminophenylboronic acid
Similarity: 0.86
[ 850568-22-8 ]
(4-((2-(Dimethylamino)ethyl)carbamoyl)phenyl)boronic acid hydrochloride
Similarity: 0.76
[ 860173-33-7 ]
(4-(Cyclopropylcarbamoyl)phenyl)boronic acid
Similarity: 0.76
[ 99349-68-5 ]
(3-Acrylamidophenyl)boronic acid
Similarity: 0.89
[ 874363-18-5 ]
N-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acrylamide
Similarity: 0.66
[ 125971-57-5 ]
2-Benzylidene-4-methyl-3-oxo-N-phenylpentanamide
Similarity: 0.51
[ 133550-35-3 ]
(E)-2-Cyano-3-(3,4-dihydroxyphenyl)-N-phenylacrylamide
Similarity: 0.50
[ 99349-68-5 ]
(3-Acrylamidophenyl)boronic acid
Similarity: 0.89
[ 101251-09-6 ]
4-Acetylaminophenylboronic acid
Similarity: 0.86
[ 1217500-61-2 ]
(2-Oxoindolin-6-yl)boronic acid
Similarity: 0.77
[ 850568-22-8 ]
(4-((2-(Dimethylamino)ethyl)carbamoyl)phenyl)boronic acid hydrochloride
Similarity: 0.76
[ 99349-68-5 ]
(3-Acrylamidophenyl)boronic acid
Similarity: 0.89
[ 101251-09-6 ]
4-Acetylaminophenylboronic acid
Similarity: 0.86
[ 850568-22-8 ]
(4-((2-(Dimethylamino)ethyl)carbamoyl)phenyl)boronic acid hydrochloride
Similarity: 0.76
[ 860173-33-7 ]
(4-(Cyclopropylcarbamoyl)phenyl)boronic acid
Similarity: 0.76